Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

23-12-2023 | Hyperparathyroidism | Editorial

Expanding the clinical indications of [¹⁸F]fluorocholine PET/CT in primary hyperparathyroidism: the evidence cannot be evaded

Authors: Giorgio Treglia, Alessio Rizzo, Arnoldo Piccardo

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 5/2024

Excerpt

Hyperparathyroidism (HPT) is defined as an excessive parathyroid hormone (PTH) production by hyperfunctioning parathyroid glands. Primary HPT is caused by autonomous single or multiple hyperfunctioning parathyroid glands often resulting in hypercalcemia, and it may occur more frequently as sporadic disease or in the context of hereditary diseases such as multiple endocrine neoplasia type 1 (MEN1) syndrome [1]. …

Expert Panel on Neurological Imaging, Zander D, Bunch PM, Policeni B, Juliano AF, Carneiro-Pla D, Dubey P, Gule-Monroe MK, Hagiwara M, Hoang JK, Jain V, Kim LT, Moonis G, Parsons MS, Rath TJ, Solórzano CC, Subramaniam RM, Taheri MR, DuCheneThoma K, Trout AT, Zafereo ME Jr, Corey AS. ACR appropriateness criteria® parathyroid adenoma. J Am Coll Radiol. 2021;18(11):406–22. https://doi.org/10.1016/j.jacr.2021.08.013.CrossRef

Treglia G, Trimboli P, Huellner M, Giovanella L. Imaging in primary hyperparathyroidism: focus on the evidence-based diagnostic performance of different methods. Minerva Endocrinol. 2018;43(2):133–43. https://doi.org/10.23736/S0391-1977.17.02685-2.CrossRefPubMed

Göbüt H, Bostanci H. The evolution of primary hyperparathyroidism publications and global productivity from past to present: a bibliometric analysis during 1980 to 2022. Medicine. 2023;102(35):e34622. https://doi.org/10.1097/MD.0000000000034622.CrossRefPubMedPubMedCentral

Quak E, Cavarec M, Ciappuccini R, Girault G, Rouzier R, Lequesne J. Detection, resection and cure: a systematic review and meta-analysis of 18F-choline PET in primary hyperparathyroidism. Q J Nucl Med Mol Imaging. 2023;67(2):122–9. https://doi.org/10.23736/S1824-4785.23.03512-4.CrossRefPubMed

Patel DD, Bhattacharjee S, Pandey AK, Kopp CR, Ashwathanarayana AG, Patel HV, Barnabas R, Bhadada SK, Dodamani MH. Comparison of 4D computed tomography and F-18 fluorocholine PET for localisation of parathyroid lesions in primary hyperparathyroidism: a systematic review and meta-analysis. Clin Endocrinol. 2023;99(3):262–71. https://doi.org/10.1111/cen.14875.CrossRef

Piccardo A, Bottoni G, Boccalatte LA, Camponovo C, Musumeci M, Bacigalupo L, Collaud C, Ugolini M, Fiz F, Trimboli P. Head-to-head comparison among ¹⁸F-choline PET/CT, 4D contrast-enhanced CT, and ¹⁸F-choline PET/4D contrast-enhanced CT in the detection of hyperfunctioning parathyroid glands: a systematic review and meta-analysis. Endocrine. 2021;74(2):404–12. https://doi.org/10.1007/s12020-021-02798-8.CrossRefPubMed

Lee SW, Shim SR, Jeong SY, Kim SJ. Direct comparison of preoperative imaging modalities for localization of primary hyperparathyroidism: a systematic review and network meta-analysis. JAMA Otolaryngol Head Neck Surg. 2021;147(8):692–706. https://doi.org/10.1001/jamaoto.2021.0915.CrossRefPubMedPubMedCentral

Bioletto F, Barale M, Parasiliti-Caprino M, Prencipe N, Berton AM, Procopio M, Deandreis D, Ghigo E. Comparison of the diagnostic accuracy of 18F-fluorocholine PET and 11C-methionine PET for parathyroid localization in primary hyperparathyroidism: a systematic review and meta-analysis. Eur J Endocrinol. 2021;185(1):109–20. https://doi.org/10.1530/EJE-21-0038.CrossRefPubMed

Whitman J, Allen IE, Bergsland EK, Suh I, Hope TA. Assessment and comparison of ¹⁸F-fluorocholine PET and <sup>99m</sup>Tc-sestamibi scans in identifying parathyroid adenomas: a metaanalysis. J Nucl Med. 2021;62(9):1285–91. https://doi.org/10.2967/jnumed.120.257303.CrossRefPubMedPubMedCentral

10.

Evangelista L, Ravelli I, Magnani F, Iacobone M, Giraudo C, Camozzi V, Spimpolo A, Cecchin D. ¹⁸F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature. Ann Nucl Med. 2020;34(9):601–19. https://doi.org/10.1007/s12149-020-01507-1.CrossRefPubMedPubMedCentral

11.

Boccalatte LA, Higuera F, Gómez NL, de la Torre AY, Mazzaro EL, Galich AM, Collaud C, Figari MF. Usefulness of 18F-fluorocholine positron emission tomography-computed tomography in locating lesions in hyperparathyroidism: a systematic review. JAMA Otolaryngol Head Neck Surg. 2019;145(8):743–50. https://doi.org/10.1001/jamaoto.2019.0574.CrossRefPubMed

12.

Broos WAM, van der Zant FM, Knol RJJ, Wondergem M. Choline PET/CT in parathyroid imaging: a systematic review. Nucl Med Commun. 2019;40(2):96–105. https://doi.org/10.1097/MNM.0000000000000952.CrossRefPubMed

13.

Treglia G, Piccardo A, Imperiale A, Strobel K, Kaufmann PA, Prior JO, Giovanella L. Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2019;46(3):751–65. https://doi.org/10.1007/s00259-018-4123-z.CrossRefPubMed

14.

Kim SJ, Lee SW, Jeong SY, Pak K, Kim K. Diagnostic performance of F-18 fluorocholine PET/CT for parathyroid localization in hyperparathyroidism: a systematic review and meta-analysis. Horm Cancer. 2018;9(6):440–7. https://doi.org/10.1007/s12672-018-0347-4.CrossRefPubMedPubMedCentral

15.

Imperiale A, Bani J, Bottoni G, Latgé A, Heimburger C, Catrambone U, Vix M, Treglia G, Piccardo A. Does ¹⁸F-fluorocholine PET/CT add value to positive parathyroid scintigraphy in the presurgical assessment of primary hyperparathyroidism? Front Med. 2023;10:1148287. https://doi.org/10.3389/fmed.2023.1148287.CrossRef

16.

Latge A, Riehm S, Vix M, Bani J, Ignat M, Pretet V, Helali M, Treglia G, Imperiale A. ¹⁸F-Fluorocholine PET and 4D-CT in patients with persistent and recurrent primary hyperparathyroidism. Diagnostics. 2021;11(12):2384. https://doi.org/10.3390/diagnostics11122384.CrossRefPubMedPubMedCentral

17.

Fiz F, Bottoni G, Massollo M, Trimboli P, Catrambone U, Bacigalupo L, Righi S, Treglia G, Imperiale A, Piccardo A. [18F]F-Choline PET/CT and 4D-CT in the evaluation of primary hyperparathyroidism: rivals or allies? Q J Nucl Med Mol Imaging. 2023;67(2):130–7. https://doi.org/10.23736/S1824-4785.23.03514-8.CrossRefPubMed

18.

Piccardo A, Trimboli P, Rutigliani M, Puntoni M, Foppiani L, Bacigalupo L, Crescenzi A, Bottoni G, Treglia G, Paparo F, Del Monte P, Lanata M, Paone G, Ferrarazzo G, Catrambone U, Arlandini A, Ceriani L, Cabria M, Giovanella L. Additional value of integrated ¹⁸F-choline PET/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile. Eur J Nucl Med Mol Imaging. 2019;46(3):766–75. https://doi.org/10.1007/s00259-018-4147-4.CrossRefPubMed

19.

Giovanella L, Bacigalupo L, Treglia G, Piccardo A. Will ¹⁸F-fluorocholine PET/CT replace other methods of preoperative parathyroid imaging? Endocrine. 2021;71(2):285–97. https://doi.org/10.1007/s12020-020-02487-y.CrossRefPubMed

20.

Petranović Ovčariček P, Giovanella L, Carrió Gasset I, Hindié E, Huellner MW, Luster M, Piccardo A, Weber T, Talbot JN, Verburg FA. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging. 2021;48(9):2801–22. https://doi.org/10.1007/s00259-021-05334-y.CrossRefPubMedPubMedCentral

21.

Bilezikian JP, Khan AA, Silverberg SJ, Fuleihan GE, Marcocci C, Minisola S, Perrier N, Sitges-Serra A, Thakker RV, Guyatt G, Mannstadt M, Potts JT, Clarke BL, Brandi ML, International Workshop on Primary Hyperparathyroidism. Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop. J Bone Miner Res. 2022;37(11):2293–314. https://doi.org/10.1002/jbmr.4677.CrossRefPubMed

22.

Boucher A, Delabie J, Lussey-Lepoutre C, Haissaguerre M, Ouvrard E, Lavinia V, Le Bras M, Batisse-Lignier M, Cuny T, Jacquet-Francillon N, Gaujoux S, Molina O, Imperiale A, Latge A, Ansquer C, Kelly A, Borson-Chazot F, Tlili G, Sebag F, Hamidou Z, Romanet P, Taïeb D. Performance of [18F]fluorocholine PET/CT in MEN1-related primary hyperparathyroidism before initial surgery or for persistent/recurrent disease. Eur J Nucl Med Mol Imaging. 2023. https://doi.org/10.1007/s00259-023-06537-1.CrossRefPubMed

23.

July M, Santhanam P, Giovanella L, Treglia G. Role of positron emission tomography imaging in multiple endocrine neoplasia syndromes. Clin Physiol Funct Imaging. 2018;38(1):4–9. https://doi.org/10.1111/cpf.12391.CrossRefPubMed

24.

Niederle B, Selberherr A, Bartsch DK, Brandi ML, Doherty GM, Falconi M, Goudet P, Halfdanarson TR, Ito T, Jensen RT, Larghi A, Lee L, Öberg K, Pavel M, Perren A, Sadowski SM, Tonelli F, Triponez F, Valk GD, O’Toole D, Scott-Coombes D, Thakker RV, Thompson GB, Treglia G, Wiedenmann B. Multiple endocrine neoplasia type 1 and the pancreas: diagnosis and treatment of functioning and non-functioning pancreatic and duodenal neuroendocrine neoplasia within the MEN1 syndrome - an international consensus statement. Neuroendocrinology. 2021;111(7):609–30. https://doi.org/10.1159/000511791.CrossRefPubMed

25.

Rizzo A, Racca M, Cauda S, Balma M, Dall'Armellina S, Dionisi B, Mossetti C, Bruna MC, Freddi M, Palestini N. 18F-fluorocholine PET/CT semi-quantitative analysis in patients affected by primary hyperparathyroidism: a comparison between laboratory and functional data. Endocrine. 2023;80(2):433–40. https://doi.org/10.1007/s12020-022-03280-9.CrossRefPubMed

Title: Expanding the clinical indications of [18F]fluorocholine PET/CT in primary hyperparathyroidism: the evidence cannot be evaded
Authors: Giorgio Treglia
Alessio Rizzo
Arnoldo Piccardo
Publication date: 23-12-2023
Publisher: Springer Berlin Heidelberg
Keyword: Hyperparathyroidism
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 5/2024
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-023-06573-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Expanding the clinical indications of [¹⁸F]fluorocholine PET/CT in primary hyperparathyroidism: the evidence cannot be evaded

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2024

Effects of medication on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice

Beyond stillness: the importance of tackling patient’s motion for reliable parametric imaging

Prediction of therapy response of breast cancer patients with machine learning based on clinical data and imaging data derived from breast [18F]FDG-PET/MRI

Advances in targeted alpha therapy of cancer

Detection of metabolic adaptation in a triple-negative breast cancer animal model with [18F]choline-PET imaging as a surrogate for drug resistance

Impact of patient motion on parametric PET imaging